Patents by Inventor Timur Gungor

Timur Gungor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-substituted cyclic amines as calcium sensing receptor modulators
    Patent number: 7105537
    Abstract: The present invention relates to modulators of the calcium sensing receptor having the formula I wherein Ar1, X, n, R1, R2, R3 and Q are as defined herein.
    Type: Grant
    Filed: January 27, 2004
    Date of Patent: September 12, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ashvinikumar V. Gavai, Roy J. Vaz, John K. Dickson, Jr., Jacques Y. Roberge, Wu Yang, Timur Gungor, James R. Corte, David P. Rotella, Yufeng Wang
  • 3-aryl-hydroxybenzoxazines and 3, 4-dihydro-3-aryl-hydroxybenzoxazines as selective estrogen receptor beta modulators
    Patent number: 7015219
    Abstract: Substituted benzoxazine and 3,4-dihydrobenzoxazine derivatives possessing activity as estrogen receptor beta (ER?) modulators are provided which have the structure of formula I wherein the substitutents are as described herein. In addition, a method is provided for preventing, inhibiting or treating the progression or onset of pathological conditions associated with the estrogen receptor and to pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: March 21, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: John K. Dickson, Timur Gungor, Wu Yang
  • Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
    Publication number: 20050267119
    Abstract: The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
    Type: Application
    Filed: May 11, 2005
    Publication date: December 1, 2005
    Inventors: Hannguang Chao, Huji Tuerdi, Timothy Herpin, Jacques Roberge, Yalei Liu, R. Lawrence, Robert Rehfuss, Charles Clark, Jennifer Qiao, Timur Gungor, Patrick Lam, Tammy Wang, Rejean Ruel, Alexandre L'Heureux, Carl Thibeault, Gilles Bouthillier, Dora Schnur
  • Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
    Publication number: 20050261244
    Abstract: The present invention provides novel ureas containing N-aryl or N-heteroaryl substituted heterocycles and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
    Type: Application
    Filed: May 10, 2005
    Publication date: November 24, 2005
    Inventors: Huji Tuerdi, Hannguang Chao, Jennifer Qiao, Tammy Wang, Timur Gungor
  • Amino-benzazoles as P2Y1 receptor inhibitors
    Publication number: 20050203146
    Abstract: The present invention provides novel amino-benzazoles and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
    Type: Application
    Filed: January 19, 2005
    Publication date: September 15, 2005
    Inventors: Timothy Herpin, George Morton, Robert Rehfuss, R. Lawrence, Michael Poss, Jacques Roberge, Timur Gungor
  • Pyrrolidine and piperidine derivatives as factor Xa inhibitors
    Publication number: 20050119266
    Abstract: The present application describes pyrrolidine and piperidine derivatives or pharmaceutically acceptable salt forms thereof. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
    Type: Application
    Filed: September 28, 2004
    Publication date: June 2, 2005
    Inventors: Yan Shi, Philip Stein, Wei Han, Timur Gungor
  • Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
    Publication number: 20050096309
    Abstract: The present application describes sulfonylaminovalerolactams and derivatives thereof of Formula Ia-If: or pharmaceutically acceptable salt forms thereof, wherein ring G is a mono- or bicyclic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
    Type: Application
    Filed: September 28, 2004
    Publication date: May 5, 2005
    Inventors: Wei Han, Zilun Hu, Timur Gungor
  • Novel thiazolidine compounds as calcium sensing receptor modulators
    Publication number: 20040242602
    Abstract: The present invention relates to modulators of the calcium sensing receptor having the formula I 1
    Type: Application
    Filed: February 10, 2004
    Publication date: December 2, 2004
    Inventors: Timur Gungor, John K. Dickson
  • Novel 2-substituted cyclic amines as calcium sensing receptor modulators
    Publication number: 20040229860
    Abstract: The present invention relates to modulators of the calcium sensing receptor having the formula I 1
    Type: Application
    Filed: January 27, 2004
    Publication date: November 18, 2004
    Inventors: Ashvinikumar V. Gavai, Roy J. Vaz, John K. Dickson, Jacques Y. Roberge, Wu Yang, Timur Gungor, James R. Corte, David P. Rotella, Yufeng Wang
  • Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors
    Publication number: 20040209863
    Abstract: The present application describes sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds and derivatives thereof of Formula I:
    Type: Application
    Filed: March 16, 2004
    Publication date: October 21, 2004
    Inventors: Donald J. Pinto, Jennifer X. Qiao, Timur Gungor, Patrick Y.S. Lam, Yun-Long Li
  • 3-Arylquinazoline derivatives as selective estrogen receptor beta modulators
    Publication number: 20030220227
    Abstract: Novel quinazoline derivatives possessing activity as estrogen receptor beta (ER&bgr;) modulators are provided which have the general formula I 1
    Type: Application
    Filed: March 13, 2003
    Publication date: November 27, 2003
    Inventors: Timur Gungor, James R. Corte
  • 3-Aryl-hydroxybenzoxazines and 3, 4-dihydro-3-aryl-hydroxybenzoxazines as selective estrogen receptor beta modulators
    Publication number: 20030195207
    Abstract: Substituted benzoxazine and 3,4-dihydrobenzoxazine derivatives possessing activity as estrogen receptor beta (ER&bgr;) modulators are provided which have the structure of formula I 1
    Type: Application
    Filed: December 18, 2002
    Publication date: October 16, 2003
    Inventors: John K. Dickson, Timur Gungor, Wu Yang
  • Adenosinergic agonist containing pharmaceutical composition with analgesic activity
    Patent number: 6015797
    Abstract: The object of the present invention is a pharmaceutical composition, which comprises, as active principle, a combination of an adenosinergic agonist and a compound selected from the opiates, benzodiazepines and NMDA antagonists.
    Type: Grant
    Filed: December 7, 1998
    Date of Patent: January 18, 2000
    Assignee: Laboratoires UPSA
    Inventors: Francoise Camborde, Alix Cloarec, Timur Gungor, Jean-Marie Teulon
  • 1,2-Diarylindole derivatives, processes for their preparation and their uses in therapeutics
    Patent number: 5723485
    Abstract: The present invention relates to the derivatives of the formula ##STR1## and to their use in therapeutics, especially as drugs with anti-inflammatory and analgesic properties.
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: March 3, 1998
    Assignee: Laboratories UPSA
    Inventors: Timur Gungor, Jean-Marie Teulon
  • Adenosine derivatives, preparation methods and pharmaceutical compositions containing them
    Patent number: 5480983
    Abstract: The present invention relates to the derivatives of the formula ##STR1## and their addition salts, and to their use in therapeutics, especially as analgesics and as antihypertensives.
    Type: Grant
    Filed: June 29, 1994
    Date of Patent: January 2, 1996
    Assignee: Laboratoires UPSA
    Inventors: Nicole Bru-Magniez, Timur Gungor, Jean-Marie Teulon
  • N6-[(Imidazo[1,2-a]pyridin-3-yl)ethyl]adenosines, their 5'-uronamide analogues and pharmaceutical compositions
    Patent number: 5459132
    Abstract: The present invention relates to the derivatives of the formula ##STR1## and their addition salts, and to their use in therapeutics as analgesics, as antihypertensives and as drugs with antiproliferative properties.
    Type: Grant
    Filed: February 15, 1994
    Date of Patent: October 17, 1995
    Assignee: Laboratoires UPSA
    Inventors: Nicole Bru-Magniez, Timur Gungor, Jean-Marie C. Teulon
  • Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
    Patent number: 5389632
    Abstract: The present invention relates to the derivatives of the formula ##STR1## and their tautomeric forms, as well as their addition salts, and to their use in therapeutics, especially for the treatment and prevention of cardiovascular diseases and in particular for the treatment of hypertension, cardiac insufficiency and diseases of the arterial wall, especially atherosclerosis.
    Type: Grant
    Filed: February 24, 1993
    Date of Patent: February 14, 1995
    Assignee: Laboratoires UPSA
    Inventors: Nicole Bru-Magniez, Timur Gungor, Jean-Marie Teulon
  • Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
    Patent number: 5387747
    Abstract: The present invention relates to the derivatives of the formula ##STR1## and their tautomeric forms, as well as their addition salts, and to their use in therapeutics, especially for the treatment and prevention of cardiovascular diseases and in particular for the treatment of hypertension, cardiac insufficiency and diseases of the arterial wall, especially atherosclerosis.
    Type: Grant
    Filed: April 16, 1993
    Date of Patent: February 7, 1995
    Assignee: Laboratoires Upsa
    Inventors: Nicole Bru-Magniez, Timur Gungor, Jean-Marie Teulon
  • Triazolopyrimidines which are angiotensin II receptor antagonists and pharmaceutical compositions in which they are present
    Patent number: 5231094
    Abstract: The present invention relates to the derivatives of the formula ##STR1## and their tautomeric forms, as well as their addition salts, and to their use in therapeutics, especially for the treatment of cardiovascular diseases and in particular for the treatment of hypertension, cardiac insufficiency and diseases of the arterial wall.
    Type: Grant
    Filed: April 6, 1992
    Date of Patent: July 27, 1993
    Assignee: Societe Anonyme: Laboratoires UPSA
    Inventors: Nicole Bru-Magniez, Timur Gungor, Jean-Marie Teulon
  • N.sup.6 -[3-(1-substituted)indolylethyl] adenosine 5'-carboxamides and their pharmaceutical compositions
    Patent number: 5229505
    Abstract: The present invention relates to the derivatives of the formula ##STR1## and their addition salts, and to their use in therapeutics, especially in the central nervous system as analgesics, anticonvulsants, antiepileptics, anxiolytics, antidepressants and neuroprotectors, and in the cardiovascular system as antiarrhythmics, antihypertensives and platelet aggregation inhibitors.
    Type: Grant
    Filed: February 7, 1992
    Date of Patent: July 20, 1993
    Assignee: LABORATOIRES UPSA
    Inventors: Nicole Bru-Magniez, Timur Gungor, Jean-Marie Teulon